PainReform Ltd. (PRFX)
2.08
0.00 (0.00%)
At close: Apr 14, 2025, 3:59 PM
2.05
-1.44%
After-hours: Apr 14, 2025, 07:59 PM EDT
0.00% (1D)
| Bid | 1.56 |
| Market Cap | 3.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.67M |
| EPS (ttm) | -32.16 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | -0.28 |
| Analyst | n/a |
| Ask | 2.59 |
| Volume | 179,185 |
| Avg. Volume (20D) | 2,327,942 |
| Open | 2.00 |
| Previous Close | 2.08 |
| Day's Range | 2.03 - 2.20 |
| 52-Week Range | 0.43 - 16.63 |
| Beta | 0.72 |
About PRFX
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the tre...
Sector Healthcare
IPO Date Sep 1, 2020
Employees 2
Stock Exchange NASDAQ
Ticker Symbol PRFX
Website https://www.painreform.com
1 month ago
+31.56%
PainReform shares are trading higher after the com...
Unlock content with
Pro Subscription
3 months ago
-28.57%
PainReform shares are trading lower. The company announced an update regarding its Phase 3 clinical trial evaluating PRF-110 in post-surgical pain management of patients undergoing bunionectomy.
